[
  {
    "ts": "2026-02-05T08:10:54+00:00",
    "headline": "Is Vertex Pharmaceuticals (VRTX) Pricing Reflect Long Term Cash Flow Potential After Recent Pullback",
    "summary": "Wondering if Vertex Pharmaceuticals at around US$470 a share is offering fair value, or if you are paying up for quality, you are not alone in asking that question. The stock is around US$470.52 after a 1.5% decline over the last 7 days, a 4.8% gain over 30 days, a 4.1% gain year to date, and a 3.7% decline over the past year, on top of a 60.4% return over 3 years and 121.4% over 5 years. Recent news coverage has focused on Vertex Pharmaceuticals as a key player in the large cap biotech...",
    "url": "https://finance.yahoo.com/news/vertex-pharmaceuticals-vrtx-pricing-reflect-081054761.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "3f898748-8d84-3cb4-8858-5145c0cc649d",
      "content": {
        "id": "3f898748-8d84-3cb4-8858-5145c0cc649d",
        "contentType": "STORY",
        "title": "Is Vertex Pharmaceuticals (VRTX) Pricing Reflect Long Term Cash Flow Potential After Recent Pullback",
        "description": "",
        "summary": "Wondering if Vertex Pharmaceuticals at around US$470 a share is offering fair value, or if you are paying up for quality, you are not alone in asking that question. The stock is around US$470.52 after a 1.5% decline over the last 7 days, a 4.8% gain over 30 days, a 4.1% gain year to date, and a 3.7% decline over the past year, on top of a 60.4% return over 3 years and 121.4% over 5 years. Recent news coverage has focused on Vertex Pharmaceuticals as a key player in the large cap biotech...",
        "pubDate": "2026-02-05T08:10:54Z",
        "displayTime": "2026-02-05T08:10:54Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/be31617c737d47553e0bc442fa8fa6d9",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ihFoSuY9PLXURl2kI_sV.w--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/be31617c737d47553e0bc442fa8fa6d9.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/bIz6sh0rX4c7ACsVP8z51w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/be31617c737d47553e0bc442fa8fa6d9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/vertex-pharmaceuticals-vrtx-pricing-reflect-081054761.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/vertex-pharmaceuticals-vrtx-pricing-reflect-081054761.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "VRTX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]